Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 274,018 |
|
|||||
| News | - | ||||||
| Day High | 2.85 | Low High |
|||||
| Day Low | 2.60 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bio Path Holdings Inc | BPTH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.1699 | -5.82% | 2.7501 | 13:40:23 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.81 | 2.60 | 2.85 | 2.92 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,382 | 274,018 | $ 2.72 | $ 745,147 | - | 2.60 - 44.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:43:47 | 10 | $ 2.765 | USD |
Bio Path Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.85M | 678.80k | - | 0 | -16.08M | -23.69 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Bio Path News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BPTH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.88 | 7.6699 | 2.60 | 4.18 | 17,344,043 | -0.1299 | -4.51% |
| 1 Month | 3.73 | 7.6699 | 2.60 | 4.18 | 4,588,923 | -0.9799 | -26.27% |
| 3 Months | 8.60 | 9.9875 | 2.60 | 4.32 | 1,568,196 | -5.85 | -68.02% |
| 6 Months | 13.026 | 14.798 | 2.60 | 5.14 | 820,682 | -10.28 | -78.89% |
| 1 Year | 28.00 | 44.80 | 2.60 | 10.67 | 1,146,517 | -25.25 | -90.18% |
| 3 Years | 123.80 | 172.398 | 2.60 | 40.24 | 527,073 | -121.05 | -97.78% |
| 5 Years | 360.00 | 486.80 | 2.60 | 93.48 | 527,841 | -357.25 | -99.24% |
Bio Path Description
| Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003. |
